(E)-N-(4-fluoro-3-(trifluoromethyl)phenyl)-3-((3-(2-(pyridin-2-yl)vinyl)-1H-indazol-6-yl)thio)propanamide

ID: ALA4476849

PubChem CID: 141764047

Max Phase: Preclinical

Molecular Formula: C24H18F4N4OS

Molecular Weight: 486.49

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  O=C(CCSc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1)Nc1ccc(F)c(C(F)(F)F)c1

Standard InChI:  InChI=1S/C24H18F4N4OS/c25-20-8-4-16(13-19(20)24(26,27)28)30-23(33)10-12-34-17-6-7-18-21(31-32-22(18)14-17)9-5-15-3-1-2-11-29-15/h1-9,11,13-14H,10,12H2,(H,30,33)(H,31,32)/b9-5+

Standard InChI Key:  PZPRLQXNZZEXAP-WEVVVXLNSA-N

Molfile:  

 
     RDKit          2D

 34 37  0  0  0  0  0  0  0  0999 V2000
   19.3977   -3.4902    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.1074   -3.0807    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.1045   -2.2581    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.3959   -1.8528    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.6897   -3.0812    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.6864   -2.2647    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.9088   -2.0155    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   17.4315   -2.6780    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   17.9141   -3.3366    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.8107   -1.8468    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   21.5199   -2.2528    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.2261   -1.8415    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.9353   -2.2474    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.6415   -1.8362    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   22.9384   -3.0646    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   17.6648   -4.1148    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.8661   -4.2880    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.6168   -5.0662    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.8184   -5.2359    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.5689   -6.0133    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.1185   -6.6193    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.9207   -6.4427    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.1664   -5.6655    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   24.3508   -2.2421    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.3510   -3.0594    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.0594   -3.4652    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.7665   -3.0539    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.7608   -2.2325    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.0518   -1.8303    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.4763   -3.4589    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   25.0638   -4.2851    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.0662   -5.0286    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   24.4036   -4.8268    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   25.7275   -4.8224    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
  5  1  1  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  6  1  0
  5  6  2  0
  6  7  1  0
  7  8  1  0
  8  9  2  0
  9  5  1  0
  3 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 13 15  2  0
  9 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
 23 18  1  0
 14 24  1  0
 24 25  2  0
 25 26  1  0
 26 27  2  0
 27 28  1  0
 28 29  2  0
 29 24  1  0
 27 30  1  0
 31 32  1  0
 31 33  1  0
 31 34  1  0
 26 31  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4476849

    ---

Associated Targets(Human)

ABL1 Tclin Bcr/Abl fusion protein (1667 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

BaF3 (4657 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 486.49Molecular Weight (Monoisotopic): 486.1137AlogP: 6.41#Rotatable Bonds: 7
Polar Surface Area: 70.67Molecular Species: NEUTRALHBA: 4HBD: 2
#RO5 Violations: 1HBA (Lipinski): 5HBD (Lipinski): 2#RO5 Violations (Lipinski): 1
CX Acidic pKa: 13.47CX Basic pKa: 4.59CX LogP: 5.58CX LogD: 5.58
Aromatic Rings: 4Heavy Atoms: 34QED Weighted: 0.23Np Likeness Score: -1.97

References

1. Liu X, Wang B, Chen C, Jiang Z, Hu C, Wu H, Zhang Y, Liu X, Wang W, Wang J, Hu Z, Wang A, Huang T, Liu Q, Wang W, Wang L, Wang W, Ren T, Li L, Xia R, Ge J, Liu Q, Liu J..  (2018)  Discovery of (E)-N-(4-((4-methylpiperazin-1-yl)methyl)-3-(trifluoromethyl)phenyl)-3-((3-(2-(pyridin-2-yl)vinyl)-1H-indazol-6-yl)thio)propanamide (CHMFL-ABL-121) as a highly potent ABL kinase inhibitor capable of overcoming a variety of ABL mutants including T315I for chronic myeloid leukemia.,  160  [PMID:30317026] [10.1016/j.ejmech.2018.10.007]

Source